Can Narrow-Network Pharmacies Lower the Cost of Specialty Medications?

|

article image
“Express Scripts Urges Narrower Coverage of Anti-Inflammatory Drugs,” that describes the steps Express Scripts is taking to reduce the cost of expensive specialty pharmacy medications like Humira and Enbrel. These two drugs are injection medications that are part of a class called TNF Alpha Inhibitors. They are a very special type of anti-inflammatory medication that are used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis and Crohn’s disease.

Spotlight

Perdaman Pharmaceuticals Ltd.

PERDAMAN Pharmaceuticals, New Delhi is the associate company of the well established PERDAMAN GROUP Of INDUSTRIES. Perdaman Pharmaceuticals was incorporated in the year 2010. Perdaman with a mission to serve the global human beings, has started with its International Business Division and wants to be one of the leading Global Pharmaceutical Company dedicated to Mankind.

OTHER ARTICLES

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 11, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | February 11, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | February 11, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Spotlight

Perdaman Pharmaceuticals Ltd.

PERDAMAN Pharmaceuticals, New Delhi is the associate company of the well established PERDAMAN GROUP Of INDUSTRIES. Perdaman Pharmaceuticals was incorporated in the year 2010. Perdaman with a mission to serve the global human beings, has started with its International Business Division and wants to be one of the leading Global Pharmaceutical Company dedicated to Mankind.

Events